About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Phase III Trial
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Phosphagenics Appoints Dr Ross Murdoch as Chief Executive Officer
January 14, 2015
Click here to read more
Post navigation
Previous Post
Ethics Approval to Commence Topical TPM®/Oxycodone Patch Trial
Next Post
Phosphagenics Decides to put its BioElixia Cosmetics Brand up for Sale
Related Posts
Phosphagenics Extends Due Diligence Period for Opioid Patches in Japan
November 10, 2016
Ethics Approval for CBD Topical Osteoarthritis Study
October 21, 2021
October 21, 2021
Phosphagenics and Mylan Agree Settlement
December 19, 2018
